Microbiome Milestones: From Market Launch to Future Trends
Pitching session summary
The pitching session aims to be an extension of the preceding panel with the goal to provide a platform for microbiome innovators in human health.
Date, time and room information
May 5, 16:15-17:00, room Rio
Moderation
| Name | Position | Institution |
|---|---|---|
| Isma Hachi | Director | IQVIA |
Pitching companies
| Company name | Pitcher | Title of presentation | Link to company website |
|---|---|---|---|
| Aurealis | Laurent Decory | ||
| Exeliom Biosciences | Benjamin Hadida | ||
| Mikrobiomik | Patricia Del Rio | ||
| REM Analytics | Paulo Refinetti | ||
| Swipebiome | Amine Zorgani | ||
| Trilliome | Patrick Guye | ||
| Yoni solutions | Virginia Franco |
Jury members
| Name | Position | Institution |
|---|---|---|
| Isabelle de Cremoux | CEO | Seventure |
| Per Falk | CEO | GC Holdings |
| Manuel Fankhauser | CEO | Seerave Foundation |
| Stefanie Zechner | Founder & Director | nextimpact |
| Isma Hachi | Director | IQVIA |
PharmaBiome AG & IQVIA AG
PharmaBiome has developed the leading microbiome drug-development platform for the design and production at scale of targeted microbiome therapeutics.
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry.
